NCT03888963

Brief Summary

The investigators will evaluate the analgesic efficacy of pulsed radiofrequency on the thoracic paravertebral nerves for patients with chronic mastalgia of fibrocystic disease of the breast

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 25, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

March 28, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2019

Completed
Last Updated

July 8, 2019

Status Verified

July 1, 2019

Enrollment Period

5 months

First QC Date

March 22, 2019

Last Update Submit

July 3, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • the changes in pain intensity measured by VAS pain score

    VAS pain score, is a scale for pain measurements scored from 0 to 10 in which 0 = no pain and 10 = the worst imaginable pain

    patients will be evaluated at 3 months postoperatively

Study Arms (2)

PRF

EXPERIMENTAL
Procedure: PRF

SHAM

SHAM COMPARATOR
Procedure: SHAM

Interventions

PRFPROCEDURE

patients will receive pulsed radiofrequency, 4 cycles (each cycle, 2 minutes) on the thoracic paravertebral nerves number 2,3, and 4 under fluroscopic guidance

PRF
SHAMPROCEDURE

patients will be subjected to the same procedure like PRF group without giving PRF

SHAM

Eligibility Criteria

Age16 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patients with chronic mastalgia due to fibrocystic disease of the breast
  • the pain duration maintained for more than 1 year
  • the pain intensity is more than 5 on VAS pain score

You may not qualify if:

  • coagulopathy
  • infection at the site of the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diab

Asyut, 71111, Egypt

RECRUITING

MeSH Terms

Conditions

Chronic Pain

Interventions

salicylhydroxamic acid

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

March 22, 2019

First Posted

March 25, 2019

Study Start

March 28, 2019

Primary Completion

August 20, 2019

Study Completion

September 20, 2019

Last Updated

July 8, 2019

Record last verified: 2019-07

Locations